0001628280-23-042492.txt : 20231221 0001628280-23-042492.hdr.sgml : 20231221 20231221160427 ACCESSION NUMBER: 0001628280-23-042492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231220 FILED AS OF DATE: 20231221 DATE AS OF CHANGE: 20231221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Almenoff June Sherie CENTRAL INDEX KEY: 0001492647 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 231505288 MAIL ADDRESS: STREET 1: C/O BRAINSTORM CELL THERAPEUTICS INC. STREET 2: 1325 AVENUE OF AMERICAS 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 wk-form4_1703192659.xml FORM 4 X0508 4 2023-12-20 0 0001534120 Avalo Therapeutics, Inc. AVTX 0001492647 Almenoff June Sherie C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 1 0 0 0 0 Stock Option (Right to Buy) 0.043 2023-12-20 4 A 0 3334 0 A 2024-12-20 2033-12-20 Common Stock 3334 3334 D The stock option will vest in full on December 20, 2024, subject to the Reporting Person's continued service on such vesting date. /s/ Jennifer Zoltoski, by Power of Attorney 2023-12-21